Cansino Biologics Stock Total Debt

688185 Stock   61.23  0.13  0.21%   
Cansino Biologics fundamentals help investors to digest information that contributes to Cansino Biologics' financial success or failures. It also enables traders to predict the movement of Cansino Stock. The fundamental analysis module provides a way to measure Cansino Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cansino Biologics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cansino Biologics Company Total Debt Analysis

Cansino Biologics' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Total Debt

 = 

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Current Cansino Biologics Total Debt

    
  1.39 B  
Most of Cansino Biologics' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cansino Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition

Cansino Net Debt

Net Debt

499.33 Million

At present, Cansino Biologics' Net Debt is projected to increase significantly based on the last few years of reporting.
Based on the latest financial disclosure, Cansino Biologics has a Total Debt of 1.39 B. This is 49.3% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The total debt for all China stocks is 73.77% higher than that of the company.

Cansino Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cansino Biologics' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cansino Biologics could also be used in its relative valuation, which is a method of valuing Cansino Biologics by comparing valuation metrics of similar companies.
Cansino Biologics is currently under evaluation in total debt category among its peers.

Cansino Fundamentals

About Cansino Biologics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cansino Biologics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cansino Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cansino Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Cansino Stock

Cansino Biologics financial ratios help investors to determine whether Cansino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cansino with respect to the benefits of owning Cansino Biologics security.